PATHOLOGICAL GRADE-SPECIFIC MARKER FOR MAKING PROGNOSIS OF AND DETERMINING TREATMENT STRATEGY FOR PROSTATE CANCER PATIENT

摘要

The present invention relates to a marker for predicting a difference in the effects of prostate cancer treatments and making a prognosis in accordance with the pathological grade of a prostate cancer patient. Since a genetic mutation of the present invention is respectively correlated with a survival rate and a recurrence rate of a prostate cancer patient of a particular pathological grade, the mutated gene of the present invention can be used as a marker for predicting a difference in the effects of prostate cancer treatments or a prognosis of the prostate cancer patient, on the basis of the pathological grade.